8-K: InnovAge Announces Fiscal Second Quarter 2025 Financial Results

InnovAge reports a 10.6% increase in total revenue for the second fiscal quarter ended December 31, 2024, but also a larger net loss compared to the same period last year.

Summary

• InnovAge Holding Corp. announced its financial results for the second fiscal quarter ended December 31, 2024.
• Total revenue increased by approximately 10.6% to $209.0 million, compared to $188.9 million in the second quarter of fiscal year 2024.
• The company reported a net loss of $13.5 million, compared to a net loss of $3.8 million in the second quarter of fiscal year 2024.
• Adjusted EBITDA decreased to $5.9 million from $6.9 million in the same quarter of the previous year.
• The company is confirming its full fiscal year 2025 financial guidance, with expected revenue between $815 million and $865 million and Adjusted EBITDA between $24 million and $31 million.
• As of December 31, 2024, InnovAge served approximately 7,480 participants across 20 centers in six states, compared to 6,780 participants in the second quarter of fiscal year 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While revenue increased, the significant increase in net loss offsets the positive aspects. The confirmation of financial guidance provides some stability, but the overall picture is mixed.

Positives

• Total revenue increased by 10.6% compared to the same quarter last year, reaching $209.0 million.
• The number of participants served increased to approximately 7,480, up from 6,780 in the prior year.
• Center-level Contribution Margin increased 10.3% compared to $33.6 million in the second quarter of fiscal year 2024.
• The company ended the quarter with $46.1 million in cash and cash equivalents plus $40.8 million in short-term investments.

Negatives

• Net loss increased significantly to $13.5 million, compared to $3.8 million in the same quarter last year.
• Adjusted EBITDA decreased by $1.0 million compared to the second quarter of fiscal year 2024.
• Loss Before Income Taxes of $13.5 million increased approximately 261.0%, compared to a Loss Before Income Taxes of $3.7 million in the second quarter of fiscal year 2024
• Adjusted EBITDA margin decreased from 3.7% to 2.8%.

Risks

• The company's future performance is subject to various risks, including the ability to obtain licenses for new centers and attract and retain participants.
• Macroeconomic challenges, such as labor shortages and inflation, could impact the business.
• Inspections, reviews, audits, and investigations by government programs could lead to adverse findings.
• Legal proceedings and litigation could be costly to defend.
• The company's revenues are dependent on a limited number of government payors.
• Submissions to government payors may contain inaccurate or unsupportable information, leading to repayment obligations or penalties.

Future Outlook

InnovAge is confirming its full fiscal year 2025 financial guidance, expecting total revenues between $815 million and $865 million and Adjusted EBITDA between $24 million and $31 million.

Management Comments

• CEO Patrick Blair stated that the second quarter results reflect meaningful progress in strengthening the business, driving top-line growth, and improving margins.
• CEO Patrick Blair stated that the company is entering calendar year 2025 with positive momentum while remaining unwavering in its commitment to delivering exceptional high quality care and creating meaningful value for participants, caregivers, regulatory partners, and our investors.

Industry Context

InnovAge operates in the Program of All-inclusive Care for the Elderly (PACE) sector, providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors. The results reflect the ongoing demand for these services, but also the challenges in managing costs and achieving profitability in this sector.

Comparison to Industry Standards

• It's difficult to provide a precise comparison without knowing the specific financial details of InnovAge's direct competitors.
• However, other companies in the healthcare services sector, such as Oak Street Health (before being acquired by CVS Health) and Alignment Healthcare, also focus on value-based care for seniors.
• These companies are often compared based on metrics like revenue growth, membership growth, and medical cost ratios.
• InnovAge's revenue growth of 10.6% is a key metric to compare against these peers.
• The net loss and Adjusted EBITDA margin are also important indicators of financial health compared to industry benchmarks.

Stakeholder Impact

• Shareholders may be concerned about the increased net loss and decreased Adjusted EBITDA.
• Participants should see continued access to care, as the company is confirming its financial guidance.
• Employees may face uncertainty due to the company's efforts to optimize business operations.
• Regulatory partners will likely monitor the company's performance and compliance with program requirements.

Key Dates